Difference between revisions of "Interferon alfa-2b (Intron-A)"
Warner-admin (talk | contribs) m (→Also known as) |
m |
||
Line 9: | Line 9: | ||
*[[Adult T-cell leukemia/lymphoma]] | *[[Adult T-cell leukemia/lymphoma]] | ||
*[[Chronic myelogenous leukemia]] | *[[Chronic myelogenous leukemia]] | ||
+ | *[[Hairy cell leukemia]] | ||
*[[Melanoma]] | *[[Melanoma]] | ||
*[[Multiple myeloma]] | *[[Multiple myeloma]] | ||
Line 90: | Line 91: | ||
[[Category:Adult T-cell leukemia/lymphoma medications]] | [[Category:Adult T-cell leukemia/lymphoma medications]] | ||
[[Category:Chronic myelogenous leukemia medications]] | [[Category:Chronic myelogenous leukemia medications]] | ||
+ | [[Category:Hairy cell leukemia medications]] | ||
[[Category:Melanoma medications]] | [[Category:Melanoma medications]] | ||
[[Category:Multiple myeloma medications]] | [[Category:Multiple myeloma medications]] |
Revision as of 14:59, 14 September 2019
General information
Class/mechanism: Immune system activator; binds to cell surface receptors that modulate many downstream intracellular signal transduction pathways. Mechanism not fully understood.[1][2][3]
Route: SC, IM, IV, intralesional
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
- Adult T-cell leukemia/lymphoma
- Chronic myelogenous leukemia
- Hairy cell leukemia
- Melanoma
- Multiple myeloma
- Neuroendocrine tumor
- Pancreatic NET
- Renal cell carcinoma
- Systemic mastocytosis
Diseases for which it was used
Patient drug information
- Interferon alfa-2b (Intron-A) patient drug information (Chemocare)[4]
- Interferon alfa-2b (Intron-A) patient drug information (UpToDate)[5]
History of changes in FDA indication
- 6/4/1986: Initial FDA approval
Also known as
Caution, may also contain names for interferon beta, interferon gamma, or interferon alfa-2a.
- Brand names:
Synonyms | |||||||
---|---|---|---|---|---|---|---|
Advaferon | Alfaferone | Berofor | Biogamma | Canferon A | |||
Cytoferon | Egiferon | Feron | Fiblaferon | Frone | |||
Finnferon-Alpha | Heberon Alfa R | Humoferon | IFN Alpha | Imufor | |||
Imukin | INF | Inferax | Infergen | Inmutag | |||
Interfero | Interferon Alfanative | Interferon Human | Interferon Leucocyticum | Interferon Lymphoblastoid | |||
Interferonum Leucocyticum | Laroferon | Multiferon | Namalvin | OIF | |||
Polyferon | Realdiron | Roceron-A | Sumiferon | Wellferon |
References
- Drugs
- Subcutaneous medications
- Intralesional medications
- Intramuscular medications
- Intravenous medications
- Immunotherapeutic
- Interferons
- Adult T-cell leukemia/lymphoma medications
- Chronic myelogenous leukemia medications
- Hairy cell leukemia medications
- Melanoma medications
- Multiple myeloma medications
- Neuroendocrine tumor medications
- Pancreatic NET medications
- Renal cell carcinoma medications
- Systemic mastocytosis medications
- FDA approved in 1986